SCNXNasdaq

Scienture Holdings, Inc.

Healthcare·Healthcare·Pre-clinical·Commack, NY, United States

Scienture Holdings, Inc. (SCNX): 4 pipeline candidates. Updated within the last hour.

6.3/10

BioSniper Score

3-factor signal · derived from public data

Cash RunwayN/A

N/A

Financial Health9.7

D/E 0.21 · 0% dilution

Pipeline Maturity2.0

Lead: Preclinical

Pipeline Breadth7.2

4 candidates

Catalyst MomentumN/A

N/A

Insider SignalN/A

N/A

A transparent, data-derived signal for Scienture Holdings, Inc.across cash runway, pipeline maturity & breadth, catalyst momentum and clinical/regulatory footprint. Each factor traces to tracked public filings — not an investment recommendation.

Key Financials

Market Cap

$15.0M

Cash

Quarterly Burn

$2.9M

Runway

Revenue

$56K

Pipeline (4 candidates)

DrugPhase
scn102Preclinical
scn104Preclinical
scn106Preclinical
scn107Preclinical

Institutional Holdings

Source: SEC Form 13F · as of Mar 2026

Institutional holders

11

Total value held

$462K

HolderSharesValue
vanguard capital management llc816,182$233K
geode capital management, llc432,186$123K
vanguard fiduciary trust co198,060$56K
xtx topco ltd47,680$14K
commonwealth equity services, llc44,798$13K
two sigma securities, llc36,445$10K
jane street group, llc27,636$8K
northern trust corp13,894$4K
citigroup inc5,547$2K
sbi securities co., ltd.55$16

Showing top 10 of 11 institutional holders of Scienture Holdings, Inc.. Sign up for the full 13F holder list and quarter-by-quarter ownership history.

·CEO: Dr. Shankar Hariharan Ph.D.

Frequently asked questions

How many drug candidates are in Scienture Holdings, Inc.'s pipeline?

Scienture Holdings, Inc. (SCNX) has 4 pipeline candidates tracked by BioSniper across SEC filings and clinical trial registrations.

What is Scienture Holdings, Inc.'s lead drug candidate?

Scienture Holdings, Inc.'s most advanced tracked candidate is scn102 (Preclinical).

What is Scienture Holdings, Inc.'s market capitalization?

Scienture Holdings, Inc.'s market capitalization is approximately $15.0M.

Who is the CEO of Scienture Holdings, Inc.?

Dr. Shankar Hariharan Ph.D. is the chief executive officer of Scienture Holdings, Inc. (SCNX).

Get the full picture on Scienture Holdings, Inc.

Deep pipeline analysis, financial trends, AI-powered investment signals, and real-time catalyst alerts.